000 | 01851 a2200601 4500 | ||
---|---|---|---|
005 | 20250516082624.0 | ||
264 | 0 | _c20120801 | |
008 | 201208s 0 0 eng d | ||
022 | _a1873-2623 | ||
024 | 7 |
_a10.1016/j.transproceed.2012.01.024 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNarumi, S | |
245 | 0 | 0 |
_aLiver transplantation for Wilson's disease in pediatric patients: decision making and timing. _h[electronic resource] |
260 |
_bTransplantation proceedings _cMar 2012 |
||
300 |
_a478-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aChelating Agents _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDecision Support Techniques |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xetiology |
650 | 0 | 4 | _aHemodiafiltration |
650 | 0 | 4 |
_aHepatolenticular Degeneration _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aJapan |
650 | 0 | 4 |
_aLiver Cirrhosis _xdiagnosis |
650 | 0 | 4 |
_aLiver Failure, Acute _xdiagnosis |
650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
650 | 0 | 4 | _aLiving Donors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPlasmapheresis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aWaiting Lists |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aUmehara, M | |
700 | 1 | _aToyoki, Y | |
700 | 1 | _aIshido, K | |
700 | 1 | _aKudo, D | |
700 | 1 | _aKimura, N | |
700 | 1 | _aKobayashi, T | |
700 | 1 | _aSugai, M | |
700 | 1 | _aHakamada, K | |
773 | 0 |
_tTransplantation proceedings _gvol. 44 _gno. 2 _gp. 478-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2012.01.024 _zAvailable from publisher's website |
999 |
_c21615210 _d21615210 |